We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Vitamin D Deficiency Linked to Aggressive Breast Cancer

By LabMedica International staff writers
Posted on 19 Oct 2010
African-American women had lower vitamin D levels than white women, and vitamin D deficiency was associated with a greater likelihood for aggressive breast cancer.

Vitamin D status was determined in blood samples from 107 women who were all diagnosed with breast cancer in the previous five years. More...
Sixty of these women were African-American, while the remaining 47 were white.

Circulating 25 hydroxyvitamin D levels were used as a marker and vitamin D deficiency was defined as a serum concentration less than 20 ng/mL. The mean serum concentration of vitamin D was 29.8 ng/mL in white women and 19.3 ng/mL in African-American women. Vitamin D deficiency was found in 60% of African-American women compared with 15% of white women. Serum levels were lowest among patients with triple-negative breast cancer, and aggressive disease was eight times more likely among patients with vitamin D deficiency.

Susan Steck, Ph.D., M.P.H., associate professor of epidemiology at the University of South Carolina, (Columbia, SC, USA), said, "We know that darker skin pigmentation acts somewhat as a block to producing vitamin D when exposed to sunlight, which is the primary source of vitamin D in most people". The findings of this study provide a foundation for a possible prevention strategy, but further studies would be required. The results of the study were presented at the Third American Association of Cancer Research Conference on the Science of Cancer Health Disparities, held in Miami, Florida, USA, September 30 – October 3, 2010.

Related Links:
University of South Carolina



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.